143.94
price down icon2.94%   -4.36
after-market Dopo l'orario di chiusura: 143.94
loading
Precedente Chiudi:
$148.30
Aprire:
$147.19
Volume 24 ore:
1.26M
Relative Volume:
0.82
Capitalizzazione di mercato:
$20.05B
Reddito:
$1.53B
Utile/perdita netta:
$-214.69M
Rapporto P/E:
-81.78
EPS:
-1.76
Flusso di cassa netto:
$-43.68M
1 W Prestazione:
-4.77%
1M Prestazione:
-8.09%
6M Prestazione:
+14.49%
1 anno Prestazione:
+57.38%
Intervallo 1D:
Value
$141.11
$148.99
Intervallo di 1 settimana:
Value
$141.11
$155.64
Portata 52W:
Value
$83.13
$183.00

Natera Inc Stock (NTRA) Company Profile

Name
Nome
Natera Inc
Name
Telefono
650-249-9090
Name
Indirizzo
13011 MCCALLEN PASS, AUSTIN, CA
Name
Dipendente
4,434
Name
Cinguettio
@nateragenetics
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
NTRA's Discussions on Twitter

Confronta NTRA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
NTRA
Natera Inc
143.94 20.05B 1.53B -214.69M -43.68M -1.76
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
500.16 196.14B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
205.85 150.17B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
415.87 34.36B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
A
Agilent Technologies Inc
116.69 33.28B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
177.39 31.62B 15.41B 1.37B 2.11B 7.50

Natera Inc Stock (NTRA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-13 Iniziato RBC Capital Mkts Outperform
2025-01-23 Iniziato Barclays Overweight
2024-06-03 Ripresa Jefferies Buy
2024-04-08 Ripresa Craig Hallum Buy
2024-02-20 Downgrade Raymond James Strong Buy → Outperform
2023-12-29 Reiterato BTIG Research Buy
2023-12-14 Iniziato Guggenheim Buy
2023-12-13 Iniziato Wolfe Research Outperform
2023-11-13 Aggiornamento Raymond James Outperform → Strong Buy
2023-09-28 Iniziato Bernstein Mkt Perform
2023-07-05 Ripresa JP Morgan Overweight
2023-05-05 Iniziato UBS Buy
2023-01-18 Aggiornamento Raymond James Mkt Perform → Outperform
2022-08-25 Iniziato Credit Suisse Outperform
2022-04-25 Iniziato Stephens Overweight
2022-03-08 Iniziato Goldman Buy
2022-01-06 Ripresa Piper Sandler Overweight
2021-10-15 Ripresa Cowen Outperform
2021-06-15 Iniziato Raymond James Mkt Perform
2021-05-25 Iniziato Wells Fargo Overweight
2021-01-28 Iniziato Truist Buy
2020-10-08 Iniziato BTIG Research Buy
2020-09-28 Iniziato Morgan Stanley Overweight
2020-09-17 Iniziato SVB Leerink Outperform
2020-06-10 Ripresa Piper Sandler Overweight
2020-05-07 Aggiornamento JP Morgan Neutral → Overweight
2018-10-05 Iniziato JP Morgan Neutral
2018-07-05 Reiterato Piper Jaffray Overweight
2017-08-07 Reiterato Morgan Stanley Overweight
2016-11-10 Reiterato The Benchmark Company Buy
2016-05-23 Reiterato The Benchmark Company Buy
2016-05-11 Reiterato The Benchmark Company Buy
2016-04-19 Iniziato The Benchmark Company Buy
2015-09-28 Aggiornamento Wedbush Neutral → Outperform
2015-08-14 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2015-08-04 Iniziato Robert W. Baird Outperform
2015-07-27 Iniziato Morgan Stanley Equal-Weight
2015-07-27 Iniziato Piper Jaffray Overweight
2015-07-27 Iniziato Wedbush Neutral
Mostra tutto

Natera Inc Borsa (NTRA) Ultime notizie

pulisher
Mar 25, 2025

Game-Changing Heart Transplant Monitoring Trial Results: 1,100+ Patient Study Could Transform Post-Surgery Care - StockTitan

Mar 25, 2025
pulisher
Mar 25, 2025

Natera’s Busy 2025 Continues - The Healthcare Technology Report.

Mar 25, 2025
pulisher
Mar 25, 2025

(PDF) Understanding the clinical genetics of kidney stone disease using the Natera Renasight panel - ResearchGate

Mar 25, 2025
pulisher
Mar 24, 2025

Is Natera, Inc. (NTRA) the Best Diagnostics Stock to Invest in Right Now? - Insider Monkey

Mar 24, 2025
pulisher
Mar 24, 2025

Natera Investors Get Class Status in Prenatal Screening Lawsuit - Bloomberg Law

Mar 24, 2025
pulisher
Mar 23, 2025

12 Best Diagnostics Stocks to Invest In Right Now - Insider Monkey

Mar 23, 2025
pulisher
Mar 21, 2025

Guardant Health gains amid $292.5M verdict against Natera over false advertising claims (update) - MSN

Mar 21, 2025
pulisher
Mar 20, 2025

Natera CFO Michael Burkes sells $115,661 in company stock By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Here’s What Lifted Natera (NTRA) in Q4 and 2024 - MSN

Mar 20, 2025
pulisher
Mar 20, 2025

Natera’s president John Fesko sells $116,099 in stock By Investing.com - Investing.com Canada

Mar 20, 2025
pulisher
Mar 20, 2025

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack - Yahoo Finance

Mar 20, 2025
pulisher
Mar 20, 2025

Natera’s chief legal officer sells $135,521 in stock By Investing.com - Investing.com Canada

Mar 20, 2025
pulisher
Mar 20, 2025

Natera president sells $149,835 in stock By Investing.com - Investing.com Canada

Mar 20, 2025
pulisher
Mar 19, 2025

Natera’s executive chairman sells $164,583 in stock By Investing.com - Investing.com Canada

Mar 19, 2025
pulisher
Mar 19, 2025

Natera CEO Chapman sells $978,677 in company stock By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Natera co-founder Sheena Jonathan sells $856,410 in stock By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Natera president sells $149,835 in stock - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Natera’s chief legal officer sells $135,521 in stock - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Natera Executives and Directors Sell Shares to Cover Tax Obligations - TradingView

Mar 19, 2025
pulisher
Mar 19, 2025

Natera CFO Michael Burkes sells $115,661 in company stock - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Natera CEO Chapman sells $978,677 in company stock - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Natera’s president John Fesko sells $116,099 in stock - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Natera co-founder Sheena Jonathan sells $856,410 in stock - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Natera’s executive chairman sells $164,583 in stock - Investing.com India

Mar 19, 2025
pulisher
Mar 18, 2025

Is Natera (NTRA) the Best Biotech Stock According to Billionaires? - Yahoo Finance

Mar 18, 2025
pulisher
Mar 17, 2025

Judge Connolly (D. Del.) Overturns $96 Million Molecular Diagnostics Jury Verdict, Finds Patents Invalid Under § 112 - JD Supra

Mar 17, 2025
pulisher
Mar 17, 2025

Is Natera, Inc. (NTRA) a Best Biotech Stock According to Billionaires? - Insider Monkey

Mar 17, 2025
pulisher
Mar 17, 2025

Natera: Strong Growth Trajectory Despite Stretched Valuation Metrics (NASDAQ:NTRA) - Seeking Alpha

Mar 17, 2025
pulisher
Mar 17, 2025

Natera Inc.: Strong Execution in Revenue Per Test Powering Our Optimism! - Smartkarma

Mar 17, 2025
pulisher
Mar 17, 2025

Natera: Solid Execution, Pricey Stock (NASDAQ:NTRA) - Seeking Alpha

Mar 17, 2025
pulisher
Mar 17, 2025

Natera: Growth Looks Unstoppable, Positive EPS Just A Matter Of Time - Seeking Alpha

Mar 17, 2025
pulisher
Mar 16, 2025

Natera Inc (NTRA) Stock Price Up 4.01% on Mar 17 - GuruFocus.com

Mar 16, 2025
pulisher
Mar 16, 2025

Natera initiated with an Outperform at RBC Capital - MSN

Mar 16, 2025
pulisher
Mar 16, 2025

Natera Sees Unusually Large Options Volume (NASDAQ:NTRA) - Defense World

Mar 16, 2025
pulisher
Mar 16, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Natera, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – NTRA - Business Wire

Mar 16, 2025
pulisher
Mar 15, 2025

RBC Capital initiates Exact Sciences with Sector Perform, Natera with Outperform - MSN

Mar 15, 2025
pulisher
Mar 15, 2025

INVESTOR DEADLINE: Natera, Inc. Investors with Substantial Losses Have Opportunity to Lead Natera Class Action Lawsuit – NTRA - Business Wire

Mar 15, 2025
pulisher
Mar 15, 2025

Natera director Marcus Gail Boxer sells $590,773 in stock By Investing.com - Investing.com South Africa

Mar 15, 2025
pulisher
Mar 15, 2025

Natera executive chairman sells $7.39 million in stock By Investing.com - Investing.com Canada

Mar 15, 2025
pulisher
Mar 14, 2025

Natera director Marcus Gail Boxer sells $590,773 in stock - Investing.com India

Mar 14, 2025
pulisher
Mar 14, 2025

Natera executive chairman sells $7.39 million in stock - Investing.com

Mar 14, 2025
pulisher
Mar 14, 2025

Natera And 2 Other Stocks That May Be Trading Below Their Estimated Value - Simply Wall St

Mar 14, 2025
pulisher
Mar 14, 2025

Natera, Inc. (NASDAQ:NTRA) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

RBC Capital Initiates Coverage of Natera (NTRA) with Outperform Recommendation - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board - Simply Wall St

Mar 13, 2025

Natera Inc Azioni (NTRA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research LH
$230.02
price down icon 0.71%
diagnostics_research WAT
$362.16
price down icon 2.27%
diagnostics_research DGX
$167.33
price up icon 0.80%
diagnostics_research MTD
$1,177.09
price down icon 1.36%
diagnostics_research IQV
$177.39
price down icon 1.10%
Capitalizzazione:     |  Volume (24 ore):